Analysis of Plasma Long-Chain Fatty Acids in Hypertensive Patients
Journal of Korean Society for Clinical Pharmacology and Therapeutics
;
: 166-179, 2011.
Article
Dans Coréen
| WPRIM
| ID: wpr-206105
ABSTRACT
BACKGROUND:
Numerous studies have suggested that polyunsaturated fatty acids (PUFAs)-supplemented diets may decrease cardiovascular morbidity and mortality. Especially, omega-3 PUFAs may exert beneficial effects to the treatment and prevention of dyslipidemias, arrhythmias, atherosclerosis, and hypertension.METHODS:
This study investigated plasma lipid profiles including total cholesterol, triglycerides (TG), LDL, HDL, and antioxidant status indicative of vitamin A, vitamin E, malondialdehyde (MDA) and distribution of plasma long-chain fatty acids (C12-C24) in 28 normal subjects and 24 hypertensive patients. Also, the correlation among PUFAs, levels of antioxidant status, and lipid profiles of the subjects were estimated.RESULTS:
The distribution of omega-3 PUFAs, saturated fatty acids, and monounsaturated fatty acids showed significant differences (P<0.05), but that of omega-6 PUFAs did not exhibit significant differences. The omega-6/omega-3 ratio exhibited 36.96 in normal group and 14.29 in the hypertensive patient group. The levels of vitamin A, vitamin E, and MDA were increased significantly in the hypertensive patient group.CONCLUSION:
PUFA levels were estimated in the hypertensive patients and normal group. The results suggest that dietary intake of proper omega-6/omega-3 ratio is needed for prevention and treatment of hypertension.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Plasma sanguin
/
Troubles du rythme cardiaque
/
Triglycéride
/
Rétinol
/
Vitamine E
/
Vitamines
/
Acides gras monoinsaturés
/
Cholestérol
/
Régime alimentaire
/
Athérosclérose
Limites du sujet:
Humains
langue:
Coréen
Texte intégral:
Journal of Korean Society for Clinical Pharmacology and Therapeutics
Année:
2011
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS